ASSESSMENT OF MINIMAL RESIDUAL DISEASE BY NEXT-GENERATION FLOW CYTOMETRY AFTER INITIAL INDUCTION THERAPY FOR ACUTE MYELOID LEUKEMIA IN A PUBLIC PEDIATRIC HOSPITAL MCC Magalhães; RM Pontes; FM Furtado; BC Guido; ACMD Santos-Junior; RA Toscano; IMQ Magalhães; R Camargo; JCM Códoba;

RELIABLE FLOW CYTOMETRY METHOD FOR MONITORING OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA AFTER BLINATUMOMAB THERAPY RM Pontes; FM Furtado; SCR Franco; RA Toscano; TF Nunes; ACS Dias; JCM Cordoba; ACMDS Junior; R Camargo; IMM Quezado;

IMPACTO DO MICROAMBIENTE TUMORAL E DE ALTERAÇÕES MOLECULARES NA RECAÍDA DE PACIENTES COM EM LEUCEMIA LINFOBLÁSTICA AGUDA DE CÉLULAS B COM ETV6::RUNX1 MM Simões; PMC Rosseti; MC Ribeiro; RM Pontes; BVM Henrique; R Camargo; BC Guido;